Hatteras Venture Advisors III, LLC

Hatteras Venture Advisors III, LLC discloses dealings in 2 companies, chiefly PhaseBio Pharmaceuticals Inc and Clearside Biomedical, Inc. We count 15 filings; the first trade dates from 7 June 2016 and the latest from 22 October 2018.

On the open market, the record shows 4 purchases worth €2.0M and 4 sales worth €205k. Taken together, the purchases exceed the sales by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. Since January 2018: 3 purchases and no sales on the market.

The median purchase comes to €627k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 24 October 2018: a transaction, in PhaseBio Pharmaceuticals Inc. The clock since the last published purchase (24 October 2018) now reads 2,938 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.